Newsfeeds - Spark Newswire

1 minute read

Avista Q4 EPS $1.05 Beats $0.78 Estimate, Sales $496.77M Beat $371.59M Estimate

Today, 10:34 AM

Avista (NYSE:AVA) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.78 by 34.62 percent. This is a 47.89 percent increase over earnings of $0.71 per share from the same period

AVA

13 minute read

Earnings

Earnings Scheduled For February 22, 2023

By Benzinga Insights

Today, 10:34 AM

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.

ACVA

1 minute read

Mizuho Downgrades Avista to Underperform, Lowers Price Target to $38

By Benzinga Newsdesk

Today, 10:34 AM

Mizuho analyst Anthony Crowdell downgrades Avista (NYSE:AVA) from Neutral to Underperform and lowers the price target from $45 to $38.

AVA

1 minute read

News

Avista Said on Dec 22, Public Counsel Filed a Petition for Reconsideration Requesting the WUTC to Reconsider Its Ruling on the Settlement Agreement

By Charles Gross

Today, 10:34 AM

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000104918/000095017022027097/ava-20221222.htm

AVA

1 minute read

Keybanc Downgrades Avista to Underweight, Announces $33 Price Target

By Benzinga Newsdesk

Today, 10:34 AM

Keybanc analyst Sophie Karp downgrades Avista (NYSE:AVA) from Sector Weight to Underweight and announces $33 price target.

AVA

1 minute read

News

Avista Issues Request For Proposals For Renewable Natural Gas

By Benzinga Newsdesk

Today, 10:34 AM

Avista, through a request for proposal (RFP), is seeking to secure renewable natural gas (RNG) resources for its customers over the long term. RNG is derived from organic waste streams that would otherwise release

AVA

12 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 23, 2022

By Benzinga Insights

Today, 10:34 AM

Upgrades

ALLY

1 minute read

Avista Q2 EPS $0.16 Misses $0.17 Estimate

By Bill Haddad

Today, 10:34 AM

Avista (NYSE:AVA) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.17 by 5.88 percent. This is a 20 percent decrease over earnings of $0.20 per share from the same period

AVA

1 minute read

Avista Confirms FY22 Consolidated EPS Guidance $1.93-$2.13, FY23 Consolidated EPS $2.42-$2.62

By Bill Haddad

Today, 10:34 AM

sta Corp. is confirming its 2022 consolidated earnings guidance with a range of $1.93 to $2.13 per diluted share. We expect to be near the lower end of this range primarily due to higher power supply costs. We are

AVA

27 minute read

Earnings Scheduled For May 4, 2022

By Benzinga Insights

Today, 10:34 AM

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

ABC